Viewing Study NCT06280716


Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
Study NCT ID: NCT06280716
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-15
First Post: 2024-02-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module